HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Itamochi Selected Research

Hiroaki Itamochi Research Topics

Disease

48Neoplasms (Cancer)
11/2022 - 08/2002
27Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 02/2002
23Carcinoma (Carcinomatosis)
12/2021 - 01/2002
9Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 12/2003
9Ovarian Epithelial Carcinoma
12/2019 - 05/2004
6Adenocarcinoma
12/2015 - 08/2002
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
12/2021 - 03/2009
4Endometrial Neoplasms (Endometrial Cancer)
01/2020 - 08/2002
3Infections
06/2016 - 02/2002
2Neoplasm Metastasis (Metastasis)
09/2020 - 01/2018
2Nausea
08/2019 - 11/2014
2Vomiting
08/2019 - 11/2014
2Disease Progression
07/2018 - 06/2006
2Endometriosis
01/2015 - 06/2013
2Breast Neoplasms (Breast Cancer)
11/2013 - 07/2005
1Body Weight (Weight, Body)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
09/2020
1Anorexia
08/2019
1Malnutrition (Nutritional Deficiencies)
08/2019
1Residual Neoplasm
06/2019
1Endometrioid Carcinoma
06/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2018
1Dyspnea (Shortness of Breath)
01/2018
1Leiomyosarcoma
01/2018
1Lymphedema (Milroy Disease)
06/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2015

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2002
12PlatinumIBA
01/2021 - 01/2002
11Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 08/2002
11Cisplatin (Platino)FDA LinkGeneric
10/2017 - 01/2002
6Bevacizumab (Avastin)FDA Link
11/2022 - 07/2010
6Biomarkers (Surrogate Marker)IBA
12/2020 - 07/2010
6taxaneIBA
11/2014 - 07/2005
5Carboplatin (JM8)FDA LinkGeneric
11/2022 - 06/2006
4Phosphotransferases (Kinase)IBA
01/2018 - 07/2005
4TOR Serine-Threonine KinasesIBA
03/2014 - 02/2010
3RNA (Ribonucleic Acid)IBA
01/2018 - 11/2013
3Docetaxel (Taxotere)FDA Link
01/2018 - 03/2004
3Irinotecan (Camptosar)FDA LinkGeneric
10/2014 - 03/2012
3Phosphatidylinositols (Phosphatidylinositol)IBA
03/2014 - 12/2007
3Antineoplastic Agents (Antineoplastics)IBA
01/2014 - 06/2002
2MicroRNAs (MicroRNA)IBA
12/2020 - 02/2010
2Chimeric Antigen ReceptorsIBA
10/2017 - 01/2017
2IntegrinsIBA
10/2017 - 01/2017
2Messenger RNA (mRNA)IBA
01/2017 - 02/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 02/2012
2Indicators and Reagents (Reagents)IBA
12/2015 - 08/2002
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
05/2015 - 06/2013
2Drug CombinationsIBA
11/2014 - 01/2014
2dactolisibIBA
08/2014 - 03/2014
2nedaplatinIBA
01/2013 - 07/2012
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2012 - 07/2010
2ErbB Receptors (EGF Receptor)IBA
10/2012 - 07/2010
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2012 - 07/2010
22- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
07/2012 - 12/2007
22- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
07/2012 - 12/2007
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2012 - 12/2007
2RetinoidsIBA
12/2008 - 02/2008
1pembrolizumabIBA
11/2022
1niraparibIBA
01/2021
1NivolumabIBA
09/2020
1Sunitinib (Sutent)FDA Link
09/2020
1N-(2-chloro-4-pyridyl)-N'-phenylureaIBA
01/2020
1CytokininsIBA
01/2020
1Dual Specificity Phosphatase 6IBA
12/2019
1Long Noncoding RNAIBA
06/2019
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
06/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1GemcitabineFDA Link
01/2018
1tyrosine receptor (receptor, tyrosine)IBA
01/2018
1Gold Sodium Thiomalate (Sodium Aurothiomalate)IBA
11/2017
1Aurora Kinase AIBA
10/2017
1Keratins (Keratin)IBA
04/2017
1VimentinIBA
04/2017
1ThyroglobulinFDA Link
01/2017
1Cadherins (E-Cadherin)IBA
01/2017
1Topotecan (Hycamtin)FDA LinkGeneric
10/2016
1farletuzumabIBA
01/2016
1ParaffinIBA
12/2015
1SERPIN-B5 (maspin)IBA
12/2015
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
12/2015
1Threonine (L-Threonine)FDA Link
09/2015
1ProteomeIBA
09/2015
1Cytidine Diphosphate (CDP)IBA
06/2015
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2015

Therapy/Procedure

30Drug Therapy (Chemotherapy)
11/2022 - 01/2002
15Therapeutics
12/2021 - 02/2002
6Hysterectomy
09/2020 - 06/2004
4Lymph Node Excision (Lymph Node Dissection)
10/2016 - 06/2004
3Neoadjuvant Therapy
10/2016 - 04/2014
3Combination Drug Therapy (Combination Chemotherapy)
10/2016 - 03/2009
1Nephrectomy
09/2020
1Radiofrequency Therapy
01/2018
1Immunotherapy
01/2017
1Operative Surgical Procedures
10/2016
1Trachelectomy
10/2016
1Minimally Invasive Surgical Procedures
10/2016
1Aftercare (After-Treatment)
06/2016
1Activities of Daily Living (ADL)
06/2015